I-Chroma CRP Test

FDA 510(k) K062981 · Boditech Diagnostics, Inc.

Substantially Equivalent

510(k) numberK062981

Submission

Device name
I-Chroma CRP Test
Applicant
Boditech Diagnostics, Inc.
East Stroudsburg, PA, US
Received
September 29, 2006
Decision date
July 13, 2007
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) statement available from FDA

Official FDA 510(k) record

Device classification

Product code
DCN – System, Test, C-Reactive Protein
Device class
Class II (moderate risk)
Regulation
21 CFR 866.5270
Specialty
Immunology

Other 510(k)s with product code DCN

510(k)DeviceApplicantDecision
K232624CardioPhase® hsCRPDCN · Traditional Siemens Healthcare Diagnostic Products GmbH11/27/2023SE
K221119RCRP Flex reagent cartridgeDCN · Special Siemens Healthcare Diagnostics, Inc.03/17/2023SE
K192072Tina-quant C-Reactive Protein IVDCN · Traditional Roche Diagnostics Operations (Rdo)02/21/2020SE
K180099Optilite High Sensitivity C-Reactive Protein KitDCN · Traditional The Binding Site Group , Ltd.10/12/2018SE
K172868Optilite C-Reactive Protein Reagent,Optilite C-Reactive Protein Calibrator,Optilite…DCN · Traditional The Binding Site Group , Ltd.02/28/2018SE
K171498MSD CRP Assay Kit and MESO SECTOR S 700 InstrumentDCN · Traditional Meso Scale Diagnostics, LLC01/12/2018SE
K161982C-Reactive Protein Kit for use on SPAPLUSDCN · Traditional The Binding Site Group04/05/2017SE
K113809Hitachi Clinical Analyzer S Test Regent Cartridge C-Reactive Protein (CRP)DCN · Traditional Hitachi Chemical Diagnostics, Inc.08/17/2012SE
K091052Piccolo C-Reactive Protein (CRP) Test SystemDCN · Traditional Abaxis, Inc.01/15/2010SE
K083444C-Reactive Protein (Latex)DCN · Traditional Roche Diagnostics Corp.03/18/2009SE

Questions and answers

When was I-Chroma CRP Test cleared by the FDA?

I-Chroma CRP Test (K062981) received a 510(k) decision of Substantially Equivalent on July 13, 2007, 287 days after the submission was received.

What is the product code of K062981?

The FDA product code is DCN – System, Test, C-Reactive Protein, a Class II (moderate risk) device regulated under 21 CFR 866.5270.